Detailed price information for Editas Medicine (EDIT-Q) from The Globe and Mail including charting and trades.
Intellia Therapeutics (NTLA) is a clinical-stage biotech firm working on CRISPR-based treatments that try to edit genes ...
Researchers altered a key step in lettuce pigment production, removing its red coloration while subtly reshaping the plant’s internal chemistry.
The Paul & Daisy Soros Fellowships for New Americans officially announced its 2026 Class of Fellows, setting a new benchmark ...
Plant abiotic stresses such as salinity and drought significantly impede plant growth and agricultural yield globally.
The gene-editing drug is designed to treat patients with elevated low-density lipoprotein cholesterol or serum triglycerides.
Stuart Orkin and Swee Lay Thein shared a Breakthrough Prize in Life Sciences for their research on genetic causes of sickle ...
Individuals that share the same deletion of a portion of chromosome 16 are at risk of developing neurodevelopmental disorders ...
It is natural to wonder whether the world is on the cusp of a nightmarish age of AI -enabled bioterrorism—and, if so, what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results